Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRAZIER LIFESCIENCES ACQUISITION CORPORATION

(FLAC)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Frazier Lifesciences Acquisition Corp. announced that it has received $5.01 million in funding from Frazier Lifesciences Sponsor LLC

12/11/2020 EDT

On December 11, 2020, Frazier Lifesciences Acquisition Corp. closed the transaction. The company has issued 501,000 units for gross proceeds of $5,010,000 in the transaction.


© S&P Capital IQ 2020
All news about FRAZIER LIFESCIENCES ACQUISITION CORPORATION
08/09FRAZIER LIFESCIENCES ACQUISITION : Management's Discussion and Analysis of Financial Condi..
AQ
06/06Certain Class B Ordinary Shares of Frazier Lifesciences Acquisition Corp. are subject t..
CI
05/24FRAZIER LIFESCIENCES ACQUISITION : Management's Discussion and Analysis of Financial Condi..
AQ
05/24FRAZIER LIFESCIENCES ACQUISITION : 10-K/A - Management's Discussion and Analysis of Financ..
AQ
05/24FRAZIER LIFESCIENCES ACQUISITION COR : Non-Reliance on Previous Financials, Audits or Inte..
AQ
03/26FRAZIER LIFESCIENCES ACQUISITION : Management's Discussion and Analysis of Financial Condi..
AQ
02/09FRAZIER LIFESCIENCES ACQUISITION COR : FLAC) added to NASDAQ Composite Index
CI
2020Frazier Lifesciences Acquisition Corp. announced that it has received $5.01 million in ..
CI
2020Frazier Lifesciences Acquisition Corp. has completed an IPO in the amount of $120 milli..
CI
2020Frazier Lifesciences Acquisition Corp. has filed an IPO in the amount of $100 million.
CI
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 0,04 M - -
Net cash 2020 1,37 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 174 M 174 M -
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float 80,6%
Chart FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Duration : Period :
Frazier Lifesciences Acquisition Corporation Technical Analysis Chart | FLAC | KYG3710A1058 | MarketScreener
Income Statement Evolution
Managers and Directors
James N. Topper Chairman & Chief Executive Officer
David J. Topper Chief Financial Officer & Director
Robert F. Baltera Independent Director
Michael F. Bigham Independent Director
Carol Giltner Gallagher Independent Director
Sector and Competitors